Insiders · IMDX

IMDX insider transactions

Insight Molecular Diagnostics Inc. (IMDX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for IMDX

• 7d
  Director Silverman Lou was granted 26,943 shares, increasing direct ownership by 74% to 63,507 units (SEC Form 4)

  4 - Insight Molecular Diagnostics Inc. (0001642380) (Issuer)
• 7d
  Director Last Andrew J. was granted 26,943 shares, increasing direct ownership by 68% to 66,452 units (SEC Form 4)

  4 - Insight Molecular Diagnostics Inc. (0001642380) (Issuer)
• 7d
  Director Arno Andrew was granted 32,331 shares, increasing direct ownership by 24% to 168,885 units (SEC Form 4)

  4 - Insight Molecular Diagnostics Inc. (0001642380) (Issuer)
• 56d
  Large owner Broadwood Partners, L.P. bought $2,032,251 worth of shares (570,184 units at $3.56) (SEC Form 4)

  4 - Insight Molecular Diagnostics Inc. (0001642380) (Issuer)
• 62d
  SEC Form 4 filed by Broadwood Partners, L.P.

  4 - Insight Molecular Diagnostics Inc. (0001642380) (Issuer)
• 84d
  SEC Form 4 filed by James Andrea S.

  4 - Insight Molecular Diagnostics Inc. (0001642380) (Issuer)
• 84d
  SEC Form 4 filed by Liu James Yang

  4 - Insight Molecular Diagnostics Inc. (0001642380) (Issuer)
• 84d
  SEC Form 4 filed by Riggs Josh

  4 - Insight Molecular Diagnostics Inc. (0001642380) (Issuer)
• 129d
  Large owner Broadwood Partners, L.P. bought $2,999,999 worth of shares (521,739 units at $5.75) (SEC Form 4)

  4 - Insight Molecular Diagnostics Inc. (0001642380) (Issuer)
• 221d
  Amendment: Chief Financial Officer James Andrea S. converted options into 50,000 shares and covered exercise/tax liability with 12,175 shares, increasing direct ownership by 25% to 189,056 units (SEC Form 4)

  4/A - Insight Molecular Diagnostics Inc. (0001642380) (Issuer)
• 230d
  Chief Financial Officer James Andrea S. converted options into 50,000 shares, increasing direct ownership by 33% to 201,231 units (SEC Form 4)

  4 - Insight Molecular Diagnostics Inc. (0001642380) (Issuer)
• 265d
  SEC Form 4 filed by VP ACCT, Cntlr, Treasurer, PAO Liu James Yang

  4 - Insight Molecular Diagnostics Inc. (0001642380) (Issuer)
• 265d
  SEC Form 4 filed by Chief Financial Officer James Andrea S.

  4 - Insight Molecular Diagnostics Inc. (0001642380) (Issuer)
• 265d
  SEC Form 4 filed by CEO and President Riggs Josh

  4 - Insight Molecular Diagnostics Inc. (0001642380) (Issuer)